What is august bioservices?
Founded in 2017, August Bioservices operates as a specialized service provider for the pharmaceutical and biotechnology industries. The company offers a comprehensive suite of solutions, including advanced research, pharmaceutical development, and manufacturing services. By positioning itself as an extension of its clients' internal teams, August Bioservices addresses the growing demand for high-integrity, persistent, and expert-led development support. Their Nashville headquarters serves as a hub for innovation, where a team of seasoned life science experts leverages deep industry knowledge to navigate the complexities of drug lifecycle management and regulatory compliance.
How much funding has august bioservices raised?
august bioservices has raised a total of $88.6M across 2 funding rounds:
Series A
$23.6M
Series B
$65M
Series A (2021): $23.6M with participation from Polaris Partners and Oak HC/FT
Series B (2022): $65M led by Oak HC/FT and Polaris Partners
Key Investors in august bioservices
Oak HC/FT
A premier venture growth-equity fund that invests in healthcare information and services, providing strategic counsel and access to an extensive network of industry leaders.
Polaris Partners
A venture capital firm specializing in backing transformational companies in the biotech and healthcare sectors, offering deep operational expertise and coaching for growth.
What's next for august bioservices?
With the infusion of capital from its latest financing, August Bioservices is well-positioned to expand its infrastructure and service offerings. The strategic focus will likely center on enhancing manufacturing capacity and deepening its research expertise to meet the evolving needs of the biotech sector. As the company continues to scale, the emphasis will remain on operational excellence and the integration of new technologies to streamline the pharmaceutical development process. This phase of growth is expected to solidify the firm's competitive advantage, enabling it to take on larger, more complex enterprise-level projects while maintaining the high standards of integrity that have defined its market presence since inception.
See full august bioservices company page
